Charles Theuer - Apr 21, 2022 Form 4 Insider Report for Tracon Pharmaceuticals, Inc. (TCON)

Role
President and CEO, Director
Signature
/s/ Scott B. Brown, Attorney-in-Fact
Stock symbol
TCON
Transactions as of
Apr 21, 2022
Transactions value $
$10,350
Form type
4
Date filed
4/25/2022, 06:00 AM
Previous filing
Apr 12, 2022
Next filing
May 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCON Common Stock Purchase $10.4K +4.5K +1.96% $2.30* 235K Apr 21, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,500 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2022.